In cancer cells, Snai2 promotes aggressiveness and resistance to therapy [17–19] by favoring cancer cell stem-like [20] and EMT properties [7, 21, 22], especially in breast cancer [23], and it supports metastasis formation by increasing plasticity, cell motility [12] and resistance to detachment-induced cell death. Here, SNAI2 is linked to cancer.